Literature DB >> 11999981

Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet.

K Moseley1, R Koch, A B Moser.   

Abstract

Blood lipid studies are reported in 25 adults and 2 adolescents with PKU who had been on phenylalanine-restricted diets for a mean period of 22.6 years (range 7-39 years). Measurements included plasma concentrations of phenylalanine, cholesterol, lipoproteins, triglycerides and fatty acid profiles, including the analysis of seven fatty acids in plasma and red blood cells. Lipid screening identified 7 subjects with significantly elevated cholesterol/HDL ratios ranging from 5.6 to 10.3. Triglyceridaemia was documented in 5 of these 7, with concentrations ranging between 0.24 and 4.5 mmol/L (219-402 mg/dl) with a mean of 3.5 mmol/L (310 mg/dl). The fatty acid analyses demonstrated slight but statistically significant reductions in the concentrations of long-chain polyunsaturated fatty acids (LCPUFA), including plasma docosahexaenoic (DHA) and arachidonic acid (AA), and red blood cell DHA concentrations. The pattern resembles that reported previously in children, but alterations in the mean levels are less severe. In six of the adult patients plasma DHA or AA concentrations were less than 50% of controls. Since DHA and AA have important physiological roles, including brain and retinal function, it is recommended that blood lipid concentrations be monitored in all patients with PKU, including adults, and that DHA and AA supplementation be provided, particularly in those patients in whom the blood concentrations of these substances are reduced significantly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999981     DOI: 10.1023/a:1015142001578

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

Review 1.  The essentiality of n-3 fatty acids for the development and function of the retina and brain.

Authors:  M Neuringer; G J Anderson; W E Connor
Journal:  Annu Rev Nutr       Date:  1988       Impact factor: 11.848

Review 2.  Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Genet Metab       Date:  2001-03       Impact factor: 4.797

3.  Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.

Authors:  J Assies; R Lieverse; P Vreken; R J Wanders; P M Dingemans; D H Linszen
Journal:  Biol Psychiatry       Date:  2001-03-15       Impact factor: 13.382

4.  Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum.

Authors:  T Moriguchi; J Loewke; M Garrison; J N Catalan; N Salem
Journal:  J Lipid Res       Date:  2001-03       Impact factor: 5.922

Review 5.  Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: therapeutic implications.

Authors:  M Martinez
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis.

Authors:  H M Su; A B Moser; H W Moser; P A Watkins
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

7.  Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia.

Authors:  C Agostoni; N Massetto; G Biasucci; A Rottoli; M Bonvissuto; M G Bruzzese; M Giovannini; E Riva
Journal:  J Pediatr       Date:  2000-10       Impact factor: 4.406

8.  Polyunsaturated fatty acid status in patients with phenylketonuria.

Authors:  P Sanjurjo; L Perteagudo; J Rodríguez Soriano; A Vilaseca; J Campistol
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Plasma and red blood cell fatty acids in peroxisomal disorders.

Authors:  A B Moser; D S Jones; G V Raymond; H W Moser
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

10.  Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention.

Authors:  C Galli; C Agostoni; C Mosconi; E Riva; P C Salari; M Giovannini
Journal:  J Pediatr       Date:  1991-10       Impact factor: 4.406

View more
  23 in total

1.  A randomized, placebo-controlled, double-blind trial of supplemental docosahexaenoic acid on cognitive processing speed and executive function in females of reproductive age with phenylketonuria: A pilot study.

Authors:  S H L Yi; J A Kable; M L Evatt; R H Singh
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-10-14       Impact factor: 4.006

2.  Nutritional Consequences of Adhering to a Low Phenylalanine Diet for Late-Treated Adults with PKU : Low Phe Diet for Adults with PKU.

Authors:  Ingrid Wiig; Kristina Motzfeldt; Elin Bjørge Løken; Bengt Frode Kase
Journal:  JIMD Rep       Date:  2012-07-01

3.  Nutritional Management of Phenylketonuria.

Authors:  Erin L Macleod; Denise M Ney
Journal:  Ann Nestle Eng       Date:  2010-06

Review 4.  Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

Authors:  Sandra C van Calcar; Denise M Ney
Journal:  J Acad Nutr Diet       Date:  2012-08       Impact factor: 4.910

5.  Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease.

Authors:  Laura M Mazer; Sarah H L Yi; Rani H Singh
Journal:  J Inherit Metab Dis       Date:  2010-03-09       Impact factor: 4.982

6.  Micronutrients, Essential Fatty Acids and Bone Health in Phenylketonuria.

Authors:  Serwet Demirdas; Francjan J van Spronsen; Carla E M Hollak; J Hanneke van der Lee; Peter H Bisschop; Fred M Vaz; Nienke M Ter Horst; M Estela Rubio-Gozalbo; Annet M Bosch
Journal:  Ann Nutr Metab       Date:  2017-03-24       Impact factor: 3.374

7.  Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.

Authors:  Bridget M Stroup; Nivedita Nair; Sangita G Murali; Katarzyna Broniowska; Fran Rohr; Harvey L Levy; Denise M Ney
Journal:  J Nutr       Date:  2018-02-01       Impact factor: 4.798

8.  Diet History Is a Reliable Predictor of Suboptimal Docosahexaenoic Acid Levels in Adult Patients with Phenylketonuria.

Authors:  T Bosdet; J Branov; C Selvage; M Yousefi; S Sirrs
Journal:  JIMD Rep       Date:  2015-03-03

9.  NORMAL FATTY ACID CONCENTRATIONS IN YOUNG CHILDREN WITH PHENYLKETONURIA (PKU).

Authors:  Stacey M Lavoie; Cary O Harding; Melanie B Gillingham
Journal:  Top Clin Nutr       Date:  2009-10-01       Impact factor: 0.508

10.  Phenylketonuria: an inborn error of phenylalanine metabolism.

Authors:  Robin A Williams; Cyril D S Mamotte; John R Burnett
Journal:  Clin Biochem Rev       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.